ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AVAH vs JNJ // PIOTROSKI F-SCORE QUALITY

Aveanna Healthcare Holdings Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: AVAH 3 — JNJ 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVAH VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AVAH JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 33.30% 67.90% -34.60 JNJ /gross-margins <GO>
Return on Invested Capital (ROIC) 15.70% 25.50% -9.80 JNJ /roic <GO>
EV/EBITDA & P/E Valuation 15.5x 18.5x -3.00 AVAH /valuation <GO>
Free Cash Flow Yield 4.35% 2.97% +1.38 AVAH /fcf-yield <GO>
Operating Margin 10.50% 34.70% -24.20 JNJ /operating-margins <GO>
Net Profit Margin 0.00% 28.50% -28.50 JNJ /net-margins <GO>
Revenue Growth (YoY) 20.20% 6.00% +14.20 AVAH /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.86 5.59 -3.73 JNJ /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 8/9 8/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 57.6 62.1 -4.50 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 23.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.89B $662.49B -$659.60B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AVAH REV JNJ REV AVAH GROSS % JNJ GROSS % AVAH FCF JNJ FCF
FY 2025 $2.43B $94.19B 33.3% 67.9% $125.9M $19.70B
FY 2024 $2.02B $88.82B 31.4% 69.1% $32.6M $19.84B
FY 2023 $1.90B $85.16B — — $22.7M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVAH // BETA —
JNJ // BETA 1.08